Gaucher disease: Lived experience of patients in the context of a French national patient therapeutic education program

2015 ◽  
Vol 114 (2) ◽  
pp. S28-S29
Author(s):  
Fabrice Camou ◽  
Arnaud Alessandrin ◽  
Eva Toussaint ◽  
Fabienne Eyquard ◽  
Martine Bonnouvrier ◽  
...  
2018 ◽  
Vol 25 (6) ◽  
pp. 1523-1525 ◽  
Author(s):  
Marine Deppenweiler ◽  
Marc Debled ◽  
Jean-Luc Robquin ◽  
Barbara Lortal-Canguilhem

Trastuzumab is a monoclonal antibody used to treat human epidermal growth receptor 2 positive (HER2+) breast cancers either by itself or in combination with other chemotherapy medication. Marketing authorization was granted for a subcutaneous form of the antibody in 2014. In this case report, we discuss our experience with a patient who took part in a therapeutic education program on self-administration of trastuzumab. We demonstrate that these types of self-administered injections are not only possible but also are toxicity-free. Based on the tolerance data and our patient’s experience, we propose that the current regulations be relaxed regarding the availability of trastuzumab subcutaneous form in order to develop a cheaper “city scheme,” i.e. self-administered injections.


2012 ◽  
Vol 15 (7) ◽  
pp. A552
Author(s):  
N. Costa ◽  
H. Derumeaux-Burel ◽  
C. Canivet ◽  
F. Ory ◽  
C. Brefel-Courbon ◽  
...  

2012 ◽  
Vol 55 (1) ◽  
pp. 306
Author(s):  
P.H. Carpentier ◽  
B. Satger ◽  
M. Barrellier ◽  
C. Menez ◽  
J. Kubina ◽  
...  

Clinics ◽  
2020 ◽  
Vol 75 ◽  
Author(s):  
Liz Avlasevicius Oliveira ◽  
Magda Maria Sales Carneiro-Sampaio ◽  
Angela Midori Matuhara ◽  
Louise Cominato ◽  
Regina Celia Turola Passos Juliani ◽  
...  

Author(s):  
Grégoire Lagger ◽  
Jorge Cesar Correia ◽  
Peter Fernandes ◽  
Frédéric Sittarame ◽  
Alain Golay

Introduction: Type 2 diabetes (T2D) reversal has been demonstrated in patients undergoing bariatric surgery or low caloric diets. Objective: To investigate the effects of therapeutic patient education alone on T2D reversal in early diagnosed patients. Methods: Seventeen T2D patients underwent a one-week therapeutic education program, followed by 12 months of 1 hour sessions every month, targeting diabetes reversal. This reversal was determined using the DiaRem score which integrates glycated hemoglobin levels and antidiabetic drug treatment. Patient’s conceptions, perceptions and motivation were assessed using a 5-dimensional psychopedagogic score. Results: After 1 year, the mean HbA1C fell from 7.2% (± 1.9) to 6.2% (± 0.8) (p < 0.05), antidiabetic drug doses decreased by 25% (p < 0.05), and the DiaRem score increased by 15% (p < 0.01), indicating a reversal of the disease, not correlated to weight loss. At the end of the study, 15 out of 17 patients had excellent glycemic control (HbA1C < 7.0%) and 4 patients had parameters compatible with partial diabetes remission. A significant improvement in glycemic control coupled with a lowering of antidiabetic drug treatment was observed. Conclusions: Following an initial therapeutic education program and regular consultation sessions thereafter, early diagnosed patients may reverse their type 2 diabetes.


Sign in / Sign up

Export Citation Format

Share Document